Diagnosis and screening of hypertrophic cardiomyopathy in children

Progress in Pediatric Cardiology

Volumn 31, Issue 1, 2011, Pages 21-27

  Dadlani, Gul H ^a,b   Harmon, William G ^c   Perez Colon, Elimarys ^b   Sokoloski, Mary C ^c   Wilmot, Ivan ^a   Lipshultz, Steven E ^c  

^a JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertrophic cardiomyopathy; Pediatrics; Screening; Sudden cardiac death

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; COST BENEFIT ANALYSIS; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GENETIC SCREENING; HEALTH CARE COST; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MEDICAL HISTORY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; SCREENING TEST;

EID: 79451475601     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2010.11.005     Document Type: Article

References (14)

1. Colan S.D., Lipshultz S.E., Lowe A.M., et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children. Findings from the pediatric cardiomyopathy registry. Circulation 2007, 115:773-781.
2. Bos J.M., Towbin J.A., Ackerman M.J. Diagnostic, prognostic and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. J Am Coll Cardiol 2009, 54(3):201-211.
3. Ferrantini C., Belus A., Piroddi N., et al. Mechanical and energetic consequences of HCM-causing mutations. J Cardiovasc Transl Res 2009, 2:441-451.
4. Ho C.Y., Lopez B., Coelho-Filho O.R., et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 2010, 363:552-563.
5. Maron B.J. Sudden death in hypertrophic cardiomyopathy. J Cardiovasc Transl Res Dec. 2009, 2(4):368-380.
6. Nistri S., Olivotto I., Girolami F., Torricelli F., Cecchi F., Yacoub M.H. Looking for hypertrophic cardiomyopathy in the community: why is it important?. J CardiovascTransl Res 2009, (2):392-397.
7. Wren C. Screening for potentially fatal heart disease in children and teenagers. Heart 2009, 95:2040-2046.
8. Maron B.J., Thompson P.D., Ackerman M.J., et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2007, 115:1643-1655.
9. Wilson M.G., Basavarajaiah S., Whyte G., et al. Efficacy of personal symptom and family history questionnaires when screening for inherited cardiac pathologies? The role of electrocardiography. Br J Sports Med 2007, 039420.
10. Wheeler M.T., Heidenreich P.A., Froelicher V.F., et al. Cost effectiveness of pre-participation screening for prevention of sudden cardiac death in young athletes. Ann Intern Med 2010, 152(5):276-286.
11. Pelliccia A., DiPaolo F.M., Quattrini F.M., et al. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med 2008, 358:152-161.
12. Fuster V., Vander Zee S., Miller M.A. Evolving anatomic, functional, and molecular imaging in the early detection and prognosis of hypertrophic cardiomyopathy. J CardiovascTransl Res 2009, (2):398-406.
13. Cardiac Arrhythmia Syndromes Foundation http://www.thecasfoundation.org.
14. National Heart Lung and blood Institute, National Institutes of Health NHLBI working group screening for sudden cardiac death, executive summary http://www.nhlbi.nih.gov.